期刊文献+

肝肾综合征与血氨水平的关系 被引量:18

Analysis of the relationship between hepatorenal syndrome and plasma ammonia
原文传递
导出
摘要 目的 分析肝硬化患者肝肾综合征(HRS)的患病率,研究HRS患者血氨水平与肾功能的关系,探讨HRS在肝性脑病发生和发展中的作用。方法收集我院2007年1月-2009年3月465例肝硬化患者以及2009年3月80例单纯肾功能障碍患者、80例健康体检者的血清和血浆,检测其肝功能(ALT、AST、Y-谷氨酰转肽酶、总胆红素、血清总蛋白、白蛋白)、肾功能(尿素氮、肌酐)指标和血氨。分别以尿素氮和肌酐为诊断标准,比较两种诊断标准的HRS患病率;分析HRS组与非HRS组及单纯肾功能障碍组之间血氨水平的差异;并对40例HRS患者肾功能指标与血氨水平的相关性进行追踪分析。结果以尿素氮为诊断标准的HRS患病率为39.6%,明显高于以肌酐为标准的17.舭(x^2=97.33,P〈0.01);以尿素氮和肌酐为标准的HRS组血氨水平分别为(57.39±48.83)μmol/L和(64.80±47.25)μmol/L,明显高于非HRS组的(47.58±36.28)μmol/L和(46.13±29.99)μmol/L(t值分别为-3.07和3.67,P值均〈0.01);单纯肾功能障碍组血氨水平为(26.59±14.34)μmol/L,明显低于肝硬化HRS组和非HRS组(P值均〈0.01),但与健康对照者组的(22.36±8.72)μmol/L比较,差异没有统计学意义(t=1.52,JD〉0.05)。HRS组追踪分析发现,血氨水平与尿素氮和肌酐呈正相关关系,相关系数分别为0.874和0.834(P值均〈0.05)。结论肝性脑病实质是肝肾肠脑综合征。肝肾综合征影响血氨水平,从而促进了肝性脑病的发生和发展。 Objective To analyze the relationship between hepatorenal syndrome (HRS) and plasma ammonia. Methods Plasma ammonia, liver and renal function of 465 patients with liver cirrhosis in our hospital, from June 2007 to March 2009, were analyzed. 80 renal dysfunction patients and 80 healthy controls were recruited in the control group. In addition, 40 patients with HRS were followed up. Results Using urea as the diagnosis standard of HRS, the morbidity rate of HRS was 39.6%, which was higher than that using creatinine as the diagnosis standard ofHRS ( x^2 = 97.33, P 〈 0.01). using urea and creatinine as the diagnosis standard of HRS, the ammonia level of HRS groups was (57.39 ±48.83)μmol/L, (64.80 ±47.25)μmol/L, which were higher than that in the non-HRS groups (t = -3.07, t = -3.67, P 〈 0.01). The ammonia level of patients with renal dysfunction was (26.59 ± 14.34) μmol/L, which was lower than that in HRS group, non- HRS group (P 〈 0.01), but there was no statistical significance between the patients with renal dysfunction and the healthy peoples [(22.36 ± 8.72) μmol/L] (t = 1.52, P 〉 0.05). The followed-up analysis of 40 patients with HRS indicated that plasma ammonia level was positively correlated with urea and creatinine, and correlation coefficients were 0.874 and 0.834 (P 〈 0.05). Conclusion Hepatic encephalopathy is liver-kidneyintestine-brain syndrome. HRS plays an important role in the development of hepatic encephalopathy.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2010年第1期45-48,共4页 Chinese Journal of Hepatology
关键词 肝性脑病 肝肾综合征 血氨 Hepatic encephalopathy Hepatorenal syndrome Plasma ammonia
  • 相关文献

参考文献17

  • 1Ott P, Larsen FS. Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal, Neurochem Int, 2004, 44: 185- 198.
  • 2Jalan R, Bernuau J. Induction of cerebral hyperemia by ammonia plus endotoxin: does hyperammonemia unlock the blood-brain barrier? J Hepatol, 2007, 47: 168-171.
  • 3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 4Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 5Arroyo V, Ginbs P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology, 1996, 23: 164-176.
  • 6Cardenas A, Gines R Hepatorenal syndrome. Clin Liver Dis, 2006, 10: 371-385.
  • 7Anand R, Harry D, Holt S, et al. Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure. Gut, 2002, 50: 111-117.
  • 8周伏喜,卢放根,吴小平,霍继荣,凌奇荷.肝肾综合征患者血浆肿瘤坏死因子-α、一氧化氮及内毒素水平变化研究[J].中国现代医学杂志,2007,17(22):2751-2753. 被引量:5
  • 9贾继东.肝肾综合征的发病机制[J].中华肝脏病杂志,2003,11(10):626-626. 被引量:28
  • 10赵守松.肝肾综合征的研究现状[J].实用肝脏病杂志,2006,9(1):58-61. 被引量:5

二级参考文献59

  • 1李聪智,谢建萍,谢玉桃,刘征波,谭德明,侯周华,杨永峰,刘菲.特利加压素治疗肝肾综合征的疗效观察[J].中国现代医学杂志,2004,14(12):132-133. 被引量:6
  • 2胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 3Aguillon D,Seguin P, Maledant Y. Hepatorenal syndrome: from physiopathology to treatment. Ann Fr Anesth Reanim, 2003,22 ( 1 ):30-8.
  • 4Bataller R, Gines P, Arroyo V, et al. Hepatorenal syndrome. Clin Liver Dis, 2002,4920:487 - 507.
  • 5Anand A, Harry D, Holt S, et al. Endothelin is an important of renal function in a rat model of acute liver and renal failure. Gut, 2002,50:111-117.
  • 6Moller S, Emmehlth C, Henriksen JH. Elevated circulating plasma endothelin- 1 concentrations in cirrhosis. J Hepatol, 1993, 19:285-290.
  • 7Bardi A, Sapunar J, Oksexlirerg D, et al. Intrarenal arterial Doppler ultrasonography in cirrhosis patients with aseites, with and without hepatorenal syndrome. Rev Med Chil, 2002, 130: 173 - 180.
  • 8Saner FH, Fruhauf NR,Schafers RF, et al. Terlipressin plus hydroxyethyl starch infusion: an effective treatment for hepatorenal syndrome. Eur J Gaslroenterol Hepatol, 2003 Aug, 15 (8) : 925 - 7.
  • 9Solanki P, Chawla A, Garg R, et al, Beneficial effects of terlipressin in hepalorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol, 2003,18 : 152-156.
  • 10Di Campli C, Zileri Dal Verme L, Andrisani MC, et al. Advances in extracolporeal detoxification by MARS dialysis in patients with liver failure. Curr Med Chem, 2003,10(4) : 341 - 8.

共引文献1770

同被引文献111

引证文献18

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部